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Supplementary Figure 2. Acquisition and surprisal analysis (SA) of spontaneous Raman 
spectra across the cell lines. a, Illustration of laser focal spots on a representative cell under 
widefield mode during spontaneous Raman spectra acquisition. Green points indicate the laser 
focal points on cells. We selected 5 points (center, top, bottom, left, right) on each cell to acquire 
Raman spectra and averaged them for one cell. We randomly chose 10 cells to represent one cell 
line. b, The comparison between SA reconstructed and experimentally obtained Raman spectra for 
individual M229, M397, M409, M381 cells. The SA plots are constructed by summing the spectral 
distribution and amplitudes of the first five resolved constraints (λ0 - λ4). The inset plots show the 












Supplementary Figure 3. Raman peak assignments of the shared constraint (constraint 0, λ0) 
































































































































Supplementary Figure 4. Validation of the assignments for the 2845 and 2940 cm-1 Raman 
peaks to lipids and proteins in Fig. 1g. a, Raman spectra of pure proteins (bovine serum albumin, 
BSA, blue) and lipids (1,2-dioleoyl phosphocholine, the highest abundant lipid in M381 cells from 
lipidomics, PC, red). 2845 cm-1 and 2940 cm-1 peaks are dash-line highlighted (the same for all 
sub-figures). b, Raman spectra from cytoplasm (red, more lipid rich) and nucleus (blue, more 
protein rich) of M381 cells. c, Raman spectra of M381 cells before (CT, control, black) and after 
protease k (ProK, red) treatment to digest most of the proteins. d, Raman spectra of M381 cells 
before (CT, black) and after triton (Triton, red) treatment to wash away most lipids. Spectra in a) 
and b) are self-normalized, in c) and d) are normalized to 2845 cm-1 and 2940 cm-1, respectively. 
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Supplementary Figure 5. SRS imaging of fixed melanoma cells. a, Illustration of SRS 
configuration. b, Representative SRS imaging of fixed melanoma cells at CH2 (top, 2845 cm-1) 
and CH3 (middle, 2940 cm-1) channels. Ratiometric images (bottom, CH2/CH3) were generated 
from the same sets of CH2 and CH3 images. Scale bar: 20 μm. c, Average single-cell CH2/CH3 
values from fixed cells for 5 cell lines (n = 30 cells per cell line examined over 3 independent 
experiments). Data are plotted as boxplots: center line indicates median; box limits indicate upper 
and lower quartiles; whiskers indicate minimum and maximum. Source data are provided as a 
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Supplementary Figure 6. The identification of de novo fatty acid synthesis as a druggable 
susceptibility for more differentiated melanoma cells. a, Top panel: cell line-dependent 
correlation between GSEA scores for the GO developmental pigmentation pathway and CH2/CH3 
ratios. Bottom panel: cell line-dependent correlation between GSEA scores for TGF beta signaling 
pathway and CH2/CH3 ratios. Each dot represents a two-dimensional relationship for one cell line. 
b, Expression level of FASN across the five different melanoma cell lines (n = 1). c, C-D region 
hyperspectral SRS (hSRS) spectra on cytoplasm in each single d7-glucose labeled melanoma cells 
for five cell lines (n = 6, 8, 6, 8, 9 for M262, M229, M397, M409, M381 respectively, data shown 
as mean ± SEM, spectra are self-normalized). d, Viability tests of melanoma cell lines under 0.2 
μM TVB-3166 (FASN inhibitor) treatment for 3 days (n = 4 independent experiments, data shown 




























































































































Supplementary Figure 7. Invasiveness assay and validation of SA of hSRS spectra from lipid 
droplets (LDs). a, Relative invasiveness of different melanoma cell lines quantified by trans-well 
assay (n = 2 independent experiments). b, The comparison between SA reconstructed and 
experimentally obtained Raman spectra for randomly selected individual lipid droplets from M262, 
M229, M397, M409, M381 cells. The SA reconstructions utilized only the first two constraints λ0 



























































































































































































Supplementary Figure 8. Validation of peak assignments in Fig. 3e, and gene expression of 
fatty acid desaturases across cell lines. a, Peak assignments of constraint 0 (λ0). The 2908 cm-1 
reference peak, cholesteryl esters band (CE, 2957 cm-1 to 2997 cm-1) and unsaturated lipids peaks 
(UL, 3022 cm-1) are indicated. b, SRS spectra for pure references of glyceryl tripalmitate (TGP), 
glyceryl trioleate (TGO), cholesteryl oleate (CO), cholesteryl linoleate (CLA) after normalization 
at 2908 cm-1. The broad band (indicated by pink shadow) ranging from 2957 cm-1 to 2997 cm-1 
features CO and CLA, and is therefore assigned to cholesteryl esters. The 3022 cm-1 peak 
(indicated by violet arrow) is assigned to unsaturated lipid (=C-H), distinct in TGO, CO, CLA. c, 





































































































































Supplementary Figure 9. Deuterated fatty acids uptake across cell lines. a, Representative C-
D channel (at 2109 cm-1) SRS imaging of melanoma cells by incubating cells with d31-palmitic 
acid (50 μM, 3 days). b, Quantification of relative C-D signals in d31-palmitic acid labeling cells 
at the single-cell level including or excluding LDs (n = 15 cells examined from 3 independent 
experiments, the C-D signal of M381 cells is normalized to 1). c, Representative C-D channel (at 
2109 cm-1) SRS imaging of melanoma cells by incubating cells with d33-oleic acid (50 μM, 3 days). 
d, Quantification of relative C-D signals in d33-oleic acid labeling cells at the single-cell level 
including or excluding LDs (n = 15 cells examined over 3 independent experiments. The C-D 
signal of M381 cells is normalized to 1. Scale bar, 20 μm. Data shown as mean ± SEM. Source 
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Supplementary Figure 10. SA of hSRS spectra on single LDs in M381 cells with drug 
treatment. a) Heatmap for scores of the top two constraints (constraint 0 (λ0) – constraint 1 (λ1)) 
by surprisal analysis of hSRS spectra on LDs in M381 cells at different treatment conditions, i.e. 
M381 control (CT), 1 μM CAY, 5 μM CAY, 10 μM CAY, 1 μM SC, 5 μM SC. Each column 
represents an individual LD and each row represents the constraint scores. n = 24, 18, 19, 17, 16, 
16 for M381 CT, 1 μM CAY, 5 μM CAY, 10 μM CAY, 1 μM SC, 5 μM SC respectively, examined 
over 3 independent experiments.  b) The average score of λ1 in a) across six treatment conditions. 
Data shown as mean ± SEM. c) Raman peak assignments for λ0 and λ1. The 3022 cm-1
 peak (violet 
arrow) is assigned to unsaturated lipids (UL) and the pink shadowed range from 2957 cm-1 to 2997 
cm-1 is assigned to cholesteryl esters (CE). 2908 cm-1 is the zero point in λ1. Source data are 
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Supplementary Figure 11. Lipidomics of CE and TAG from M381 cells show the involvement 
of both MUFA and PUFA. Bulk lipidomics of M381 cells with relative percentages of different 
fatty acid chains in CE (n = 3 independent experiments, left) and in TAG (n = 3 independent 
experiments, right). Data shown as mean ± SEM. Lipidomics data are provided as Supplementary 
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Lipid composition of CE in M381 
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Supplementary Figure 12. Viability assays of melanoma cell lines under different days of 1 
μM CAY treatment. a, Dependence of viability for cell lines on the treatment length with 1 μM 
CAY. b-e, Bar-chart plot for comparing viability in (a) across five cell lines after 2-day (b), 3-day 
(c), 4-day (d), and 5-day (e) of CAY treatment. n = 4 independent experiments, Data shown as 





















































































































1 μM CAY 2 day1 μM CAY 1 μM CAY 3 day







Supplementary Figure 13. The mesenchymal M381 is sensitive to saturated fatty acids (SFA) 
related lipotoxicity. a, Relative viability of cells treated with major SFAs (PA, 16:0 and ST, 18:0), 
and major MUFAs (PO, 16:1 and OA, 18:1) at indicated concentration for 3 days (n = 4 
independent experiments). b, Relative invasiveness of control M381 cells (normalized to 100%) 
and M381 cells after treating with 1 μM CAY, 50 μM PA or 50 μM ST for 3 days. n = 4 
independent experiments. c, Concentration changes of PA (16:0) and PO (16:1) fatty acid chains 
in the 6 main species of lipids with (3 days, CAY, purple) and without (CT, pink) CAY treatment 
from lipidomics (n = 3 independent experiments). d, Concentration changes of PC and PE with (3 
days, CAY, purple) and without (CT, pink) CAY treatment from lipidomics (n = 3 independent 
experiments). e, Relative invasiveness of control M381 cells (normalized to 100%) and M381 after 
treating with 1 μM CAY, 1 μM CAY plus 5 μM OA for 3 days (n = 4 independent experiments). 
f, Two color pulse-chase experiments. Top scheme: M381 cells were firstly incubated in medium 
c
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containing 5 μM CAY for 60 h (pulse), then the medium was changed to fresh medium containing 
20 μM d33-OA but not CAY for 10 h (chase). Representative SRS images at the C-H lipid channel 
and the C-D channel were shown at two time points of 60 h (1 set, i.e. only pulsed) and 70 h (2 
sets, i.e. pulse-chased representative cells are squared). g, Relative viability of 1 μM CAY treated 
M381 cells without (CT) or with rescue of 1 μM indicated unsaturated fatty acid (UFA) for 3 days 
(n = 4 independent experiments). PO: Palmitoleic acid; LA: Linoleic acid; ALA: Alpha-linoleic 
acid; EPA: Eicosapentaenoic acid; AA: Arachidonic acid. (n = 4 independent experiments). h, 
Relative viability of 5 μM CAY treated M381 cells without (CT) or with rescue of 5 μM indicated 
UFA for 3 days (n = 4 independent experiments). i, Representative ER stress marker expression 
with (3 days, purple) and without (pink) CAY treatment (n = 2 independent experiments). Scale 
bars, 20 μm. Data shown as mean ± SEM. Lipidomics data are provided as Supplementary Data 1. 







Supplementary Table 1. The genes list in Supplementary Figure 1. S1-S4 columns each 
indicates the top 100 ranked metabolic genes uniquely upregulated in the melanocytic (S1), 
transitory (S2), neural crest (S3) and undifferentiated (S4) phenotypes in Supplementary Figure 1.  
Rank S1 top 100 S2 top 100 S3 top 100 S4 top 100 Rank S1 top 100 S2 top 100 S3 top 100 S4 top 100
1 TYR RXYLT1 ST8SIA5 NNMT 51 PDE6B GLUD2 HS6ST3 TYMP
2 DCT ALDH1A1 GALNT5 MGST1 52 HSD17B8 LPL NPR2 RDH10
3 GYG2 CYP27A1 DHRS3 GDA 53 QDPR CERS1 BST1 PNMT
4 GMPR NPR1 ALDH1A3 BCAT1 54 GCNT3 GUCY2C BHMT2 AGPAT4
5 PNPLA4 ATP6V0A4 CYB5R2 MGAT5B 55 PFKFB2 PDE7B CSGALNACT1 PDE9A
6 QPRT GALNT5 NT5E HS6ST3 56 CYP19A1 ASAH1 PDE7B ALDOC
7 RENBP TYRP1 PLA2G7 MTAP 57 ST8SIA1 LDHD GSTM3 PDE1C
8 ADCY2 UROC1 CHST1 GALNT14 58 GSTO2 FMO4 CYP27C1 CYP24A1
9 GALNT3 FOLH1 ACOX2 B3GALNT1 59 NAT8L CKMT1B PDE9A NME7
10 GAPDHS GAL3ST1 PDE1C ANPEP 60 MGST1 EPHX2 AK5 MFNG
11 TYRP1 ST8SIA1 B3GNT7 PTGS2 61 RDH8 CSGALNACT1 AK6 DSE
12 PRDM7 B3GALT1 GALNT13 CHST15 62 GALNT12 TPK1 INMT TXNRD1
13 ADCY1 TYR B3GNT5 HS3ST3A1 63 HSD3B7 ALDH1A3 DDO B3GNT3
14 PIP5K1B DGKI B3GALT2 HS3ST3B1 64 PIK3C2B BAAT ACSS3 PCK1
15 ALDOC ENPP2 MGLL CYP2S1 65 CKMT1A PCYT1B P4HA3 CA2
16 ATP6V0D2 ACP5 DPYD PTGES 66 INPP4B PDE2A ABHD17C NME3
17 BAAT B3GNT7 AKR1C3 GUCY1A2 67 MAOA SCD5 DGKA B4GALT1
18 LPIN3 ALDH2 AKR1C1 NMNAT2 68 LFNG ELOVL2 PLCE1 PGM2L1
19 PLB1 DCT ST6GALNAC5 LFNG 69 ATP8 CRYL1 SYNJ2 CYP26A1
20 CA14 NT5E TBXAS1 DPYD 70 CHAC1 B3GALT2 HSD17B3 SYNJ2
21 CHSY3 ST6GAL1 ELOVL4 ALPP 71 ALDH3B2 CKMT1A NMRK1 PLCD3
22 PTGDS ST8SIA5 ABAT CYP1B1 72 PLCG2 CA12 PDE10A ACOT4
23 LDHC COLGALT2 MGST2 CDS1 73 NAT8 ENPP1 GFPT2 UGCG
24 TKTL1 CYP7B1 AKR1B10 GALNT6 74 NAT8B ACOT12 COX7A1 AMPD3
25 OGDHL ASPA UGT8 AOX1 75 PDE11A CYP19A1 ME1 GGT5
26 PKLR POLR2F PIK3CG ASS1 76 GALM PIK3CG GAD1 KYNU
27 ACP5 EXTL1 HS3ST5 AKR1C3 77 ARG2 PRDM7 ACSM4 RRM2
28 CA8 RENBP PHGDH PLA2G16 78 GSTA1 CNDP1 OPLAH NMNAT3
29 UGT2B7 XYLT1 LPL B3GALT5 79 CKB ABAT DSE NQO1
30 GLUL ST3GAL6 EXTL1 ST6GAL2 80 PLD1 INPP5F PLA2G4C HS6ST2
31 PDE3B MAN1C1 HEPH GPX3 81 HSD17B6 GPD1 B3GAT1 EXT1
32 GUCY1A2 LARGE1 GPX7 MAN1A1 82 ACOT4 IL4I1 PIGZ MBOAT7
33 CKMT1B LARGE2 NMNAT2 XDH 83 PIP4K2A MGAT5 HS3ST3A1 PDE6B
34 SELENOI GAPDHS CHST2 AK5 84 ST6GALNAC3 FADS2 AMT PDE4D
35 ACSBG1 TBXAS1 PCYT1B AK6 85 ISYNA1 DGKG TUSC3 GLUL
36 GALC PDE3B ALDH2 INPP5J 86 ST6GALNAC1 HYAL1 FADS2 NSD1
37 PIK3CD PDE3A A4GALT CPT1C 87 MAT1A CHST11 ENPP4 NSD2
38 CYP1A1 CHST6 B4GALNT1 ENPP4 88 CYP24A1 BBOX1 UXS1 NSD3
39 ATP6V0A4 GSTM1 CHST7 CA8 89 RDH12 ACOX2 NOS2 ENTPD8
40 NPL MAT1A ANPEP ACSL5 90 ACER2 GDPD1 ALDH3B1 TCIRG1
41 HNMT MGAM AOX1 PDE11A 91 PDE5A ADCY2 XDH CYP27C1
42 MGAT4A MGAM2 FOLH1 HSD17B2 92 HYAL1 PIGZ MFNG HACD1
43 NMRK2 GALNT3 ETHE1 DGKE 93 HSD3B2 GLDC IDS PLOD2
44 B3GALT4 CA14 RXYLT1 PIK3CD 94 B3GALNT1 DDO PLCH1 GCK
45 MTAP ENPP3 VNN1 GBGT1 95 ASAH1 GNS INPP5F GSTM3
46 ST3GAL6 CHST7 PLOD2 GALC 96 MTMR8 PDXP BCAT1 BDH1
47 FHIT GSTA4 TPH1 PDE5A 97 LDHD ACSL1 PGM3 ALDH1L2
48 PNLIPRP3 UGT2B7 CHST3 MOCOS 98 PDE4D FHIT GCNT1 ADK
49 HOGA1 HS3ST1 GALNT18 SPTLC3 99 HS6ST2 HOGA1 PTGES IPMK
50 DGKE MOGAT1 HS3ST1 ALPG 100 GSTO1 PNPLA4 A3GALT2 MARS
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Melanoma cell line Phenotype IC50 to vemurafenib (nM) Mutational status
M262 melanocytic 150
BRAFV600E mutant 









M397 transitory 132 BRAFV600E mutant
M409 neural-crest-like 1018 BRAFV600E mutant
M381 mesenchymal >100000 BRAFV600E mutant
